Dr. Naman Jain
is MD Medicine, DNB Clinical Immunology and Rheumatology, working at Ramakrishna Care hospital
Dr. Naman Jain is MD Medicine, DNB Clinical Immunology and Rheumatology, Consultant Rheumatologist at Ramakrishna Care hospital, Raipur Chhattisgarh.
Rheumatoid arthritis (RA) and cardiovascul... more»Rheumatoid arthritis (RA) and cardiovascular health are closely linked. In this article, the author has delved into the complex relationship between rheumatoid arthritis and cardiovascular disease, highlighting the underlying mechanisms, shared risk factors, and implications for clinical management. «less
Jun 05, 2023
Generic drugs have become an essential par... more»Generic drugs have become an essential part of the healthcare system, providing affordable access to essential medications for millions of people worldwide. This article explains how generic medicines differ from branded drugs and what are counterfeit generic medicines. «less
May 01, 2023
Antibiotics are drugs used for the treatme... more»Antibiotics are drugs used for the treatment of bacterial infections and have no action on viruses, fungi, or parasites.This article discusses the Indian scenario of antibiotic resistance and misuse along with its impact on mankind. «less
Mar 01, 2023
Pathergy phenomenon is a state of non-spec... more»Pathergy phenomenon is a state of non-specific hypersensitive tissue response to minor trauma. The pathergy test has a high diagnostic value that helps clinicians to choose the right therapy and also helps inform of complications if any. «less
May 15, 2022
Fever of unknown origin (FUO) is one of th... more»Fever of unknown origin (FUO) is one of the most difficult challenges in clinical medicine. Its epidemiology has changed over time with advanced diagnostics and imaging available. A multidisciplinary approach, the advent of newer diagnostics and imaging can improve evaluation & management. «less
Jan 31, 2022
Osteoarthritis is one of the predominant c... more»Osteoarthritis is one of the predominant causes of morbidity and disability worldwide. But of late, advanced technologies, metabolomics, proteomics, and genomics have helped in better understanding of the pathogenesis, development of clinically relevant markers and therapeutic targets. «less
Dec 28, 2021
Raynaud's phenomenon is a common clinical ... more»Raynaud's phenomenon is a common clinical symptom caused by an exaggerated vascular response to triggers like cold. Proper clinical history, laboratory diagnosis and imaging can help clinicians in looking for the underlying causes. «less
Dec 24, 2021
Methotrexate has the potential of causing ... more»Methotrexate has the potential of causing various adverse events with higher doses or may be ineffective if given at inappropriate doses. Here we present 11 important points to keep in mind when prescribing Methotrexate in order to ensure better efficacy and safety. «less
Dec 01, 2021
Uric acid plays multiple roles as danger s... more»Uric acid plays multiple roles as danger signals during an innate immune response, maintaining electrolyte balance, and blood pressure regulation. This article elaborates on the various factors that are associated with hyperuricemia and the approach for managing uric acid levels. «less
Oct 11, 2021
VEXAS syndrome is a monogenic disease that... more»VEXAS syndrome is a monogenic disease that is mostly seen in men and is caused by somatic mutations in UBA1 in hematopoietic progenitor cells. Patients are seen to develop inflammatory and hematologic symptoms in this condition. This article explains the epidemiology, serology and treatment of this «less
Aug 07, 2021
The paraneoplastic musculoskeletal syndrom... more»The paraneoplastic musculoskeletal syndrome is not uncommon but quite often missed in busy outpatient clinics because of its mimicking and masquerading nature. Doctors play a key role in diagnosing and referring the patient to the required line of treatment. «less
Jul 07, 2021
